TEP1 and myeloid sarcoma: Our study found that the TEP1 rs1713418 GG genotype was associated with 2.2-fold increased odds of MS occurrence in individuals older than 44 years compared with the AG and AA genotypes (OR: 2.191, (95% CI: 1.020–4.708), p = 0.044).